resveratrol has been researched along with lutein in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JL; Liu, NC; Sheu, SJ | 1 |
| Fernández-García, V; Fernández-Robredo, P; García-García, L; García-Layana, A; Heras-Mulero, H; Ivanescu, AA; Moreno-Orduna, M; Recalde, S; Redondo-Exposito, A; Sádaba-Echarri, LM | 1 |
| Fischer, T | 1 |
| Bee, YS; Chen, JL; Chen, YA; Lin, SH; Sheu, SJ; Shu, CW | 1 |
| Davidov-Pardo, G; Li, YO; McClements, DJ; Sancho-Madriz, M; Shukla, V; Steiner, BM | 1 |
| Abraldes, MJ; Caballero Arredondo, M; Calvo, P; Escobar-Barranco, JJ; Fernández-Robredo, P; García-Layana, A; Hernandez, M; Hernández-Galilea, E; Lopez-Sabater, MC; Mendez-Martínez, S; Nascimento, J; Olmedilla-Alonso, B; Pardiñas-Barón, N; Recalde, S; Silva, R; Zapata, MA | 1 |
1 review(s) available for resveratrol and lutein
| Article | Year |
|---|---|
[Pharmacological therapy of age-related macular degeneration based on etiopathogenesis].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Aspirin; Bosentan; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infliximab; Lutein; Macular Degeneration; Melatonin; PPAR gamma; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Resveratrol; Stilbenes; Sulfonamides; Trimetazidine; Tumor Necrosis Factor-alpha; Ubiquinone; Vitamin D; Xanthophylls | 2015 |
1 trial(s) available for resveratrol and lutein
| Article | Year |
|---|---|
A Randomized Study of Nutritional Supplementation in Patients with Unilateral Wet Age-Related Macular Degeneration.
Topics: Aged; Aged, 80 and over; Dietary Supplements; Docosahexaenoic Acids; Female; Humans; Lutein; Macular Degeneration; Male; Middle Aged; Nutrients; Phenylethyl Alcohol; Resveratrol; Treatment Outcome; Visual Acuity; Xanthophylls; Zeaxanthins | 2021 |
4 other study(ies) available for resveratrol and lutein
| Article | Year |
|---|---|
Resveratrol protects human retinal pigment epithelial cells from acrolein-induced damage.
Topics: Acrolein; Antioxidants; Cells, Cultured; Cytoprotection; Drug Synergism; Humans; Hydrogen Peroxide; Lutein; Meclofenamic Acid; Oxidative Stress; Phagocytosis; Resveratrol; Retinal Pigment Epithelium; Smoking; Stilbenes; Xanthophylls; Zeaxanthins | 2010 |
Modifying Choroidal Neovascularization Development with a Nutritional Supplement in Mice.
Topics: Animals; Carrier Proteins; Choroid; Choroidal Neovascularization; Dietary Supplements; Disease Models, Animal; Drug Therapy, Combination; Fatty Acids, Omega-3; Fluorescein Angiography; Intravitreal Injections; Lutein; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Minerals; NLR Family, Pyrin Domain-Containing 3 Protein; Real-Time Polymerase Chain Reaction; Resveratrol; Stilbenes; Vascular Endothelial Growth Factor A; Vitamins | 2015 |
Differential autophagic effects of vital dyes in retinal pigment epithelial ARPE-19 and photoreceptor 661W cells.
Topics: Animals; Autophagy; Cell Survival; Cells, Cultured; Chloroquine; Coloring Agents; Humans; Indocyanine Green; Lutein; Mice; Protective Agents; Resveratrol; Retinal Pigment Epithelium; Rosaniline Dyes; Stilbenes; Ubiquinone; Vitrectomy | 2017 |
Encapsulation of Lutein in Nanoemulsions Stabilized by Resveratrol and Maillard Conjugates.
Topics: Caseins; Dextrans; Drug Compounding; Drug Stability; Emulsions; Lutein; Resveratrol; Temperature | 2019 |